<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04630314</url>
  </required_header>
  <id_info>
    <org_study_id>04</org_study_id>
    <nct_id>NCT04630314</nct_id>
  </id_info>
  <brief_title>Covered Stents in Treatment of Coronary Artery Perforation</brief_title>
  <acronym>CRACK</acronym>
  <official_title>Procedural and 1-year Outcomes Following Large Vessel Coronary Artery Perforation Treated by Covered Stents Implantation: Multicentre CRACK Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Silesia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Silesia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Covered stents have been mainly used for treatment of potentially life-threatening coronary&#xD;
      artery perforation and coronary artery aneurysm. Prior studies suggest that the use of&#xD;
      covered stents improves event-free survival, enabling a life-threatening situation to be&#xD;
      managed without emergency surgery and with significantly reduced rates of mortality, cardiac&#xD;
      tamponade, and major adverse cardiac events. Although the devices are used for a long time,&#xD;
      very limited study has described procedural-related outcomes with this specific technology.&#xD;
      We therefore want to report procedural, in-hospital and long term outcomes among patients&#xD;
      treated with the covered stents.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2009</start_date>
  <completion_date type="Actual">November 1, 2020</completion_date>
  <primary_completion_date type="Actual">November 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Major Adverse Cardiac Events (MACE)</measure>
    <time_frame>1 year</time_frame>
    <description>MACE</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stent Thrombosis (ST)</measure>
    <time_frame>1 year</time_frame>
    <description>ST</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac Death</measure>
    <time_frame>1 year</time_frame>
    <description>CV Death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target Lesion Revascularization (TLR)</measure>
    <time_frame>1 year</time_frame>
    <description>TLR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial Infarction (MI)</measure>
    <time_frame>1 year</time_frame>
    <description>MI</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">119</enrollment>
  <condition>Coronary Artery Perforation</condition>
  <arm_group>
    <arm_group_label>Consecutive patients treated with covered stents post PCI CAP</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Percutaneus Coronary Intervention</intervention_name>
    <description>Covered Stent</description>
    <arm_group_label>Consecutive patients treated with covered stents post PCI CAP</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All consecutive patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Iatrogenic, peri-PCI CAP treated with covered stent implantation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  CAP caused due to other cause than PCI&#xD;
&#xD;
          -  PCI of other vascular territories during the same procedure&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Department of Invasive Cardiology, Medical University of Białystok</name>
      <address>
        <city>Białystok</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>First Department of Cardiology, Medical University of Gdansk</name>
      <address>
        <city>Gdańsk</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wojciech Wańha</name>
      <address>
        <city>Katowice</city>
        <zip>40-055</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Second Department of Cardiology, Jagiellonian University Medical College</name>
      <address>
        <city>Kraków</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Miedziowe Centrum Zdrowia S.A.</name>
      <address>
        <city>Lubin</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Third Department of Cardiology, Medical University of Katowice</name>
      <address>
        <city>Zabrze</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 13, 2020</study_first_submitted>
  <study_first_submitted_qc>November 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 16, 2020</study_first_posted>
  <last_update_submitted>November 13, 2020</last_update_submitted>
  <last_update_submitted_qc>November 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Silesia</investigator_affiliation>
    <investigator_full_name>Wojciech Wańha</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Percutaneous coronary intervention</keyword>
  <keyword>Coronary artery perforation</keyword>
  <keyword>Covered stent</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

